Field study of dried blood spot specimens for HIV-1 drug resistance genotyping - Wikidata - awgldk - TriplyDB

Field study of dried blood spot specimens for HIV-1 drug resistance genotyping

Field study of dried blood spot specimens for HIV-1 drug resistance genotyping

http://www.wikidata.org/entity/Q34058841

about

Antiretroviral treatment outcome in HIV-1-infected patients routinely followed up in capital cities and remote areas of Senegal, Mali and Guinea-Conakry.Performance characteristics of finger-stick dried blood spots (DBS) on the determination of human immunodeficiency virus (HIV) treatment failure in a pediatric population in Mozambique.Comparison of Matrix-Based and Filter Paper-Based Systems for Transport of Plasma for HIV-1 RNA Quantification and Amplicon Preparation for Genotyping.Impact of Human Immunodeficiency Virus Drug Resistance on Treatment of Human Immunodeficiency Virus Infection in Children in Low- and Middle-Income Countries.Alternative Sample Types for HIV-1 Antiretroviral Drug Resistance Testing.Utilization of dried blood spot specimens can expedite nationwide surveillance of HIV drug resistance in resource-limited settings

P2860

Q34745289-24D867A5-3243-44FE-B018-ECEA326EFA4A Q40124082-8C7A17F4-2214-4BEB-9F69-20CB587D5FDB Q40715383-2F051289-7979-411B-8003-CD23371AE002 Q45326130-6925DEE7-4C83-44F8-B2AE-DE156D7F9F3A Q47613741-DC799462-D612-4247-AAB0-205AB748023E Q58760170-535B084F-7037-4B63-8DAC-2026352F40CF

P2860

Field study of dried blood spot specimens for HIV-1 drug resistance genotyping

http://www.wikidata.org/entity/Q34058841

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Field study of dried blood spot specimens for HIV-1 drug resistance genotyping

@ast

Field study of dried blood spot specimens for HIV-1 drug resistance genotyping

@en

Field study of dried blood spot specimens for HIV-1 drug resistance genotyping

@nl

type

label

Field study of dried blood spot specimens for HIV-1 drug resistance genotyping

@ast

Field study of dried blood spot specimens for HIV-1 drug resistance genotyping

@en

Field study of dried blood spot specimens for HIV-1 drug resistance genotyping

@nl

prefLabel

Field study of dried blood spot specimens for HIV-1 drug resistance genotyping

@ast

Field study of dried blood spot specimens for HIV-1 drug resistance genotyping

@en

Field study of dried blood spot specimens for HIV-1 drug resistance genotyping

@nl

P1433

Q34058841-2F9E9B74-E5BF-42D5-9FDB-FDAA853BBDB3

P1476

Q34058841-77BEFDAF-8582-4C0E-8CDE-3E82DD138FB6

P2093

Q34058841-1BA1C500-9114-4990-8348-BB296267F79C

Q34058841-1BB59301-0047-428E-A8E3-22DA76C81FB3

Q34058841-1D695720-D4D4-4287-9D90-1A10DFA6DF84

Q34058841-24F5F396-8FF4-4AA9-B228-7104DD5BC59B

Q34058841-280E54C9-B422-45D8-9FFF-F411A86B7F4F

Q34058841-4FBA255A-5ED8-48FF-8E74-5530D0278B7B

Q34058841-7528D577-04FE-4AE5-BADE-0A984B98072A

Q34058841-B32E2FB6-B33C-4A9C-9E4D-D176E092F0B5

Q34058841-C0433179-D3C2-46DB-B3A8-7DEBDD381AC4

Q34058841-D2BF1709-99D8-425C-ADA1-9E6EA4DBC488

P2860

Q34058841-194C2E73-0DD8-4A69-8C48-6242E5832FE7

Q34058841-1A20A904-97E6-415A-836A-A3A12A573F02

Q34058841-21F9D6C4-E2D8-48B7-84BE-E71DDFDF89D4

Q34058841-31C832A1-6677-482E-B4A5-81026CC32471

Q34058841-33951C24-8DE9-4085-AAF7-4ACEC8FABCF6

Q34058841-3BEE1C94-9877-455D-9298-CB8D565582C2

Q34058841-4A806469-2316-4028-956D-9E95FF95645F

Q34058841-4A96356A-C239-4E53-B4A5-C4196853B2C6

Q34058841-545DE526-AFF0-4ED7-94E0-AF7F004AAF78

Q34058841-5B357CBD-3529-4735-83E7-C30966215298

P304

Q34058841-CC3B5555-BAA7-4EAA-9304-A585DA15D6B2

P31

Q34058841-8ACFEDE3-40C6-408A-A2B7-3B270C95C382

P356

Q34058841-10F5C818-3ADB-4F0F-9514-027E6DF64084

P407

Q34058841-B9173942-D51C-40C4-9AD7-1E5F11B8DDEE

P433

Q34058841-034DCFF5-B40D-4835-94FC-1D7150C0A9BD

P478

Q34058841-311AA909-090A-47A0-82B4-8311B124B61E

P50

Q34058841-DE685B37-AC1C-4C69-94D9-FBDAAD18AF02

P577

Q34058841-FF309FFC-E6BD-48D3-8443-CB966507C79D

P698

Q34058841-329F742C-AD89-47BE-84F7-4A93E07E2F73

P932

Q34058841-175FBD85-CCDA-4A02-9C04-7F9E837B676C

P356

P1433

Journal of Clinical Microbiology

P1476

Field study of dried blood spot specimens for HIV-1 drug resistance genotyping

@en

P2093

B Magambo

http://www.w3.org/2001/XMLSchema#string

C M Parry

http://www.w3.org/2001/XMLSchema#string

C Yang

http://www.w3.org/2001/XMLSchema#string

F Lyagoba

http://www.w3.org/2001/XMLSchema#string

G Zhang

http://www.w3.org/2001/XMLSchema#string

J DeVos

http://www.w3.org/2001/XMLSchema#string

K Diallo

http://www.w3.org/2001/XMLSchema#string

M R Jordan

http://www.w3.org/2001/XMLSchema#string

N Parkin

http://www.w3.org/2001/XMLSchema#string

P Kaleebu

http://www.w3.org/2001/XMLSchema#string

P2860

Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach

MEGA5: Molecular Evolutionary Genetics Analysis Using Maximum Likelihood, Evolutionary Distance, and Maximum Parsimony Methods

Optimization of a low cost and broadly sensitive genotyping assay for HIV-1 drug resistance surveillance and monitoring in resource-limited settings

Development and application of a broadly sensitive dried-blood-spot-based genotyping assay for global surveillance of HIV-1 drug resistance.

HIV-1 drug resistance testing from dried blood spots collected in rural Tanzania using the ViroSeq HIV-1 Genotyping System

Rates of emergence of HIV drug resistance in resource-limited settings: a systematic review.

Use of dried-blood-spot samples and in-house assays to identify antiretroviral drug resistance in HIV-infected children in resource-constrained settings

Evaluation of dried blood spots for human immunodeficiency virus type 1 drug resistance testing.

Evaluation of in-house genotyping assay performance using dried blood spot specimens in the Global World Health Organization laboratory network.

Feasibility of detecting human immunodeficiency virus type 1 drug resistance in DNA extracted from whole blood or dried blood spots.

P304

2868-2875

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JCM.00544-14

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-05-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24871219

http://www.w3.org/2001/XMLSchema#string

P932

4136191

http://www.w3.org/2001/XMLSchema#string